NGT BioPharma Consultants understands the challenges companies face when selecting a clinical candidate and progressing into preclinical development activities. To increase the efficiency of this process, we work collaboratively with our clients to provide a clear assessment of an asset’s attributes, including risks, to ensure critical experiments are prioritized. We can then provide a comprehensive plan to navigate the many interdependent preclinical processes, expediting your asset’s path into the clinic.
We leverage our collective expertise and extensive experience to generate fit-for-purpose progression plans and provide this consultancy in close alignment with NGT consultants experienced in Nonclinical Sciences, CMC, Regulatory, and Quality/Compliance. Services include, but are not limited to, the following:
Although NGT is neither a laboratory or manufacturing services provider, we can serve as your single point of contact to our network of reputable CRO’s and CDMO ’s.